Tag: treatments

• Survivor Support & Clinical Trials: Neftaly offers supportive services—like transport, housing, and nutrition—to oncology patients and volunteers through programs such as the Southern Africa Youth Project Southern Africa YouthNeftaly.
• Youth Development & Donations: They facilitate donations and youth development initiatives in areas such as Lebowakgomo, but these are general social support efforts rather than medical interventions Neftaly+1.

No evidence was found indicating direct involvement in pediatric hematology or blood disorder treatments (e.g., sickle cell management, thalassemia, hemophilia).

---

Pediatric Hematology & Oncology Services in South Africa

While Neftaly isn’t directly involved, there are established healthcare providers specializing in pediatric hematology and oncology across South Africa:

• Tygerberg Hospital (Stellenbosch University)
  Handles both malignant (e.g., leukemia, lymphoma) and benign hematological conditions—including hemophilia, von Willebrand disease, sickle cell disease, ITP, and aplastic anemia. Comprehensive care includes access to multidisciplinary support such as social work, psychology, dietetics, physiotherapy, and long‑term follow-up clinics Stellenbosch University.
• Notable Specialists
  • Dr. Anel van Zyl (Tygerberg Children’s Hospital): Consultant pediatric oncologist with a specific interest in benign hematological disorders (e.g., sickle cell disease, inherited bleeding disorders). Since 2008, she’s directed the pediatric hemophilia clinic saccsg.co.za.
  • Dr. Monica Vaithilingum: Practicing pediatric hematologist in Durban, actively managing both benign and malignant hematological conditions, and running an accredited chemotherapy unit saccsg.co.za.
• Support Infrastructure & Protocols
  • SACCSG (South African Children’s Cancer Study Group) focuses on improving childhood cancer outcomes through collaborative protocols, studies, and future expansion of palliative care saccsg.co.za.
  • SUCCOUR Initiative: A Sub‑Saharan African project aimed at improving supportive care for children with cancer—focusing on areas such as febrile neutropenia, nutrition, treatment abandonment, and the development of local guidelines through educational workshops and outcome evaluations PMC.
  • Rasburicase Cost‑Effectiveness Study: A study at Red Cross War Memorial Children’s Hospital demonstrated that using rasburicase for tumor lysis syndrome is more cost‑effective than dialysis, saving an average of R 40,989.64 per patient and reducing hospital stays by about 10 days sajo.org.za.

---

Summary Comparison

Aspect	Neftaly	Established Pediatric Hematology/Oncology in SA
Direct treatment of blood disorders	No documented involvement	Yes — Tygerberg Hospital, consultants, clinics
Benign hematologic disorders	Not currently represented	Treated (e.g., hemophilia, sickle cell, ITP, inherited disorders)
Specialist clinicians	Not noted	Yes — Dr. Anel van Zyl, Dr. Monica Vaithilingum
Supportive care protocols	General supportive & clinical trial volunteer support	Yes — SUCCOUR (supportive care), Rasburicase protocols, SACCSG collaborative initiatives
Clinical trials / research	Supporting oncology trial volunteers	Institutional participation in research and trials

---

Path Forward: Possible Engagement for Neftaly

If Neftaly is interested in expanding into pediatric hematology or blood disorder support, here are potential avenues:

1. Partner with Clinical Units
   Collaborate with entities like Tygerberg Hospital for support programs (e.g., nutritional aid, psychosocial support) tailored to children with blood disorders.
2. Assist Hemophilia Clinics
   Contribute to programs like the pediatric hemophilia clinic led by Dr. Anel van Zyl—offering caregiver support, transport, or access facilitation.
3. Educational & Community Outreach
   Raise awareness of conditions like sickle cell disease or thalassemia through workshops, screenings, or informational campaigns in partnership with credible medical bodies.
4. Integrate Supportive Care Models
   Join initiatives like SUCCOUR to help develop and implement local supportive care guidelines, especially for resource‑limited settings.
5. Facilitate Access to Cost‑Effective Treatments
   Support dissemination or subsidization of proven, cost‑saving treatments like rasburicase, especially in settings facing financial constraints.

---